Oncolytics Biotech, Inc. (ONCY)

1.00 -0.05 (-4.76%) USD  |  NASDAQ  |  Jan 15, 10:06
More

Oncolytics Biotech Return on Net Operating Assets

Return on Net Operating Assets Chart

View Return on Net Operating Assets for ONCY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Return on Net Operating Assets Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Return on Net Operating Assets Range, Past 5 Years

View Return on Net Operating Assets Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Return on Net Operating Assets Benchmarks

View Return on Net Operating Assets Benchmarks
Start Trial
Aurinia Pharmaceuticals, Inc. Upgrade
Edesa Biotech, Inc. Upgrade
Lexaria Bioscience Corp. Upgrade
Xenon Pharmaceuticals, Inc. Upgrade
ProMIS Neurosciences, Inc. Upgrade

Return on Net Operating Assets Related Metrics

Return on Equity Upgrade
Return on Assets Upgrade
Return on Invested Capital Upgrade